With 0.59 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.61 million shares. The 52-week range on UTI shows that it touched its highest point at $30.56 and its lowest point at $13.66 during that stretch. It currently has a 1-year price target of $33.60. Beta for the stock currently stands at 1.50.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of UTI was up-trending over the past week, with a rise of 4.30%, but this was up by 9.59% over a month. Three-month performance surged to 49.08% while six-month performance rose 66.93%. The stock gained 96.03% in the past year, while it has gained 13.30% so far this year. A look at the trailing 12-month EPS for UTI yields 0.97 with Next year EPS estimates of 1.07. For the next quarter, that number is 0.12. This implies an EPS growth rate of 33.33% for this year and 7.00% for next year.
Float and Shares Shorts:
At present, 54.37 million UTI shares are outstanding with a float of 49.93 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for UTI since 3 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.71627 being high and $0.69835 being low. For UTI, this leads to a yearly average estimate of $0.70833. Based on analyst estimates, the high estimate for the next quarter is $0 and the low estimate is $0. The average estimate for the next quarter is thus $0.
